Insight Molecular Diagnostics (IMDX) Receivables (2020 - 2026)
Insight Molecular Diagnostics (IMDX) reported Receivables of $192,000 for Q2 2026, down 62.5% from $512,000 a year earlier but up 22.3% from the prior quarter.
Insight Molecular Diagnostics (IMDX) Receivables (2020 - 2026) Analysis & Trends
At the end of FY2025, Insight Molecular Diagnostics posted Receivables of $1.13 million, down 30.1% from FY2024.
- Receivables has a five-year compound annual growth rate of 40.9% (FY2020 to FY2025).
- By year, Receivables came in at $1.61 million in FY2024 (+233.3%), $484,000 in FY2023 (-75.9%), $2.01 million in FY2022 (+40.0%) and $1.44 million in FY2021 (+607.9%).
- Five-year quarterly Receivables spans a low of $85,000 in Q2 2024 and a high of $3.54 million in Q1 2025.
- Year over year, Receivables has now declined in each of the last three quarters, with growth averaging 72.3% over the last seven quarters.
- The high point for year-over-year Receivables in five years was Q4 2021 (growth of 607.9%); the low point was Q1 2026 (a decline of 95.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $157,000 (Q1 2026), $1.13 million (Q4 2025) and $258,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.84 Bn | 229.99 Bn | 4.88 Bn | 11.14 Bn |
| 2 | Abbott Laboratories | 174.73 Bn | 145.82 Bn | 7.27 Bn | 8.60 Bn |
| 3 | Danaher | 159.85 Bn | 143.67 Bn | 3.61 Bn | 3.97 Bn |
| 4 | Intuitive Surgical | 146.79 Bn | 126.35 Bn | 1.96 Bn | 1.67 Bn |
| 5 | Medtronic | 114.54 Bn | 80.41 Bn | 6.34 Bn | 6.36 Bn |
| 6 | Stryker | 105.67 Bn | 91.79 Bn | 4.50 Bn | 3.74 Bn |
| 7 | Boston Scientific | 63.93 Bn | 58.94 Bn | 3.85 Bn | 3.05 Bn |
| 8 | Becton Dickinson | 50.12 Bn | 47.27 Bn | 2.32 Bn | 2.36 Bn |
| 9 | Edwards Lifesciences | 50.06 Bn | 34.17 Bn | 1.35 Bn | 955.70 Mn |
| 10 | Insight Molecular Diagnostics | 103.74 Mn | 27.46 Mn | 157,000.00 | 192,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 192,000.00 |
| Mar 31, 2026 | 157,000.00 |
| Dec 31, 2025 | 1.13 Mn |
| Sep 30, 2025 | 258,000.00 |
| Jun 30, 2025 | 512,000.00 |
| Mar 31, 2025 | 3.54 Mn |
| Dec 31, 2024 | 1.61 Mn |
| Sep 30, 2024 | 209,000.00 |
| Jun 30, 2024 | 85,000.00 |
| Mar 31, 2024 | 161,000.00 |
| Dec 31, 2023 | 484,000.00 |
| Sep 30, 2023 | 593,000.00 |
| Jun 30, 2023 | 593,000.00 |
| Mar 31, 2023 | 1.40 Mn |
| Dec 31, 2022 | 2.01 Mn |
| Sep 30, 2022 | 1.99 Mn |
| Jun 30, 2022 | 1.80 Mn |
| Mar 31, 2022 | 2.12 Mn |
| Dec 31, 2021 | 1.44 Mn |
| Sep 30, 2021 | 1.03 Mn |
Insight Molecular Diagnostics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=IMDX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "IMDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=IMDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();